1
|
Kramarova EP, Lyakhmun DN, Tarasenko DV, Borisevich SS, Khamitov EM, Yusupova AR, Korlyukov AA, Romanenko AR, Shmigol TA, Bylikin SY, Baukov YI, Negrebetsky VV. Reaction of Picolinamides with Ketones Producing a New Type of Heterocyclic Salts with an Imidazolidin-4-One Ring. Molecules 2023; 29:206. [PMID: 38202789 PMCID: PMC10780162 DOI: 10.3390/molecules29010206] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/02/2023] [Revised: 12/20/2023] [Accepted: 12/22/2023] [Indexed: 01/12/2024] Open
Abstract
Reactions of picolinamides with 1,3-propanesultone in methanol followed by the treatment with ketones led to a series of previously unknown chemical transformations, yielding first pyridinium salts (2a-f), with a protonated endocyclic nitrogen atom, and then heterocyclic salts (3a-j) containing an imidazolidin-4-one ring. The structures of intermediate and final products were determined by IR and 1H, 13C NMR spectroscopy, and X-ray study. The effects of the ketone and alcohol structures on the product yield were studied by quantum-chemical calculations. The stability of salts 3a-j towards hydrolysis and alcoholysis makes them excellent candidates for the search for new types of biologically active compounds.
Collapse
Affiliation(s)
- Eugenia P. Kramarova
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Dmitry N. Lyakhmun
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Dmitry V. Tarasenko
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Sophia S. Borisevich
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Edward M. Khamitov
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Alfia R. Yusupova
- Ufa Institute of Chemistry, Oktyabrya Aven., 71, 450054 Ufa, Russia; (S.S.B.); (E.M.K.); (A.R.Y.)
| | - Alexander A. Korlyukov
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
- A.N.Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, Bl. 1, 119334 Moscow, Russia;
| | - Alexander R. Romanenko
- A.N.Nesmeyanov Institute of Organoelement Compounds of Russian Academy of Sciences, Vavilova St. 28, Bl. 1, 119334 Moscow, Russia;
- D.I. Mendeleev Russian University of Chemical Technology, Miusskaya Sq., 9, 125047 Moscow, Russia
| | - Tatiana A. Shmigol
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | | | - Yuri I. Baukov
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| | - Vadim V. Negrebetsky
- Institute of Pharmacy and Medical Chemistry, Pirogov Russian National Research Medical University, Ostrovityanov St., Bl. 1, 117997 Moscow, Russia; (E.P.K.); (D.N.L.); (D.V.T.); (A.A.K.); (T.A.S.); (Y.I.B.)
| |
Collapse
|
2
|
Zorc B, Perković I, Pavić K, Rajić Z, Beus M. Primaquine derivatives: Modifications of the terminal amino group. Eur J Med Chem 2019; 182:111640. [PMID: 31472472 PMCID: PMC7126120 DOI: 10.1016/j.ejmech.2019.111640] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/10/2019] [Revised: 08/21/2019] [Accepted: 08/21/2019] [Indexed: 02/07/2023]
Abstract
Numerous modifications of the well-known antimalarial drug primaquine, both at the quinoline ring and at the primary amino group, have been reported, mostly to obtain antimalarial agents with improved bioavailability, reduced toxicity and/or prolonged activity. Modifications of the terminal amino group were made with the main idea to prevent the metabolic pathway leading to inactive and toxic carboxyprimaquine (follow-on strategy), but also to get compounds with different activity (repurposing strategy). The modifications undertaken until 2009 were included in a review published in the same year. The present review covers various classes of primaquine N-derivatives with diverse biological profiles, prepared in the last decade by our research group as well as the others. We have summarized the synthetic procedures applied for their preparation and discussed the main biological results. Several hits for the development of novel antiplasmodial, anticancer, antimycobacterial and antibiofilm agents were identified.
Collapse
Affiliation(s)
- Branka Zorc
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, HR-10 000, Zagreb, Croatia.
| | - Ivana Perković
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, HR-10 000, Zagreb, Croatia
| | - Kristina Pavić
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, HR-10 000, Zagreb, Croatia
| | - Zrinka Rajić
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, HR-10 000, Zagreb, Croatia
| | - Maja Beus
- University of Zagreb Faculty of Pharmacy and Biochemistry, Department of Medicinal Chemistry, A. Kovačića 1, HR-10 000, Zagreb, Croatia
| |
Collapse
|
3
|
Attorresi CI, Bonifazi EL, Ramírez JA, Gola GF. One-step synthesis of N,N'-substituted 4-imidazolidinones by an isocyanide-based pseudo-five-multicomponent reaction. Org Biomol Chem 2019; 16:8944-8949. [PMID: 30452056 DOI: 10.1039/c8ob02229a] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/19/2022]
Abstract
A pseudo-five-multicomponent reaction involving an isocyanide, a primary amine, two molecules of formaldehyde and water is reported, which gives N,N'-substituted 4-imidazolidinones when trifluoroethanol is used as the solvent. The reaction proceeds with good yields and with a wide variety of amines and isocyanides, providing an efficient new entry to these heterocycles. A preliminary study of the reaction mechanism suggests that trifluoroethanol, although acting as the solvent, is directly involved as a reagent in the reaction pathway.
Collapse
Affiliation(s)
- Cecilia I Attorresi
- Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Ciudad Autónoma de Buenos Aires, C1428EGA, Argentina
| | | | | | | |
Collapse
|
4
|
Aguiar L, Machado M, Sanches-Vaz M, Prudêncio M, Vale N, Gomes P. Coupling the cell-penetrating peptides transportan and transportan 10 to primaquine enhances its activity against liver-stage malaria parasites. MEDCHEMCOMM 2019; 10:221-226. [PMID: 30881610 PMCID: PMC6390471 DOI: 10.1039/c8md00447a] [Citation(s) in RCA: 10] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 09/05/2018] [Accepted: 11/13/2018] [Indexed: 01/30/2023]
Abstract
Novel primaquine-cell penetrating peptide conjugates were synthesised and tested in vitro against liver stage Plasmodium berghei parasites. Generally, the conjugates were more active than the parent peptides and, in some cases, than the parent drug. These are unprecedented findings that may open a new route towards antimalarial drug rescuing.
Collapse
Affiliation(s)
- Luísa Aguiar
- LAQV-REQUIMTE , Departamento de Química e Bioquímica , Faculdade de Ciências , Universidade do Porto , Rua do Campo Alegre 687 , P-4169-007 Porto , Portugal .
| | - Marta Machado
- Instituto de Medicina Molecular João Lobo Antunes , Faculdade de Medicina , Universidade de Lisboa , Avenida Professor Egas Moniz , P-1648-028 Lisboa , Portugal
| | - Margarida Sanches-Vaz
- Instituto de Medicina Molecular João Lobo Antunes , Faculdade de Medicina , Universidade de Lisboa , Avenida Professor Egas Moniz , P-1648-028 Lisboa , Portugal
| | - Miguel Prudêncio
- Instituto de Medicina Molecular João Lobo Antunes , Faculdade de Medicina , Universidade de Lisboa , Avenida Professor Egas Moniz , P-1648-028 Lisboa , Portugal
| | - Nuno Vale
- Laboratório de Farmacologia , Departamento de Ciências do Medicamento , Faculdade de Farmácia , Universidade do Porto , Rua de Jorge Viterbo Ferreira 228 , P-4050-313 Porto , Portugal
- Ipatimup/Instituto de Investigação e Inovação em Saúde (i3S) , Rua Alfredo Allen, 208 , 4200-135 Porto , Portugal
| | - Paula Gomes
- LAQV-REQUIMTE , Departamento de Química e Bioquímica , Faculdade de Ciências , Universidade do Porto , Rua do Campo Alegre 687 , P-4169-007 Porto , Portugal .
| |
Collapse
|
5
|
Vale N, Ferreira A, Matos J, Fresco P, Gouveia MJ. Amino Acids in the Development of Prodrugs. Molecules 2018; 23:E2318. [PMID: 30208629 PMCID: PMC6225300 DOI: 10.3390/molecules23092318] [Citation(s) in RCA: 38] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/23/2018] [Revised: 08/30/2018] [Accepted: 09/06/2018] [Indexed: 01/03/2023] Open
Abstract
Although drugs currently used for the various types of diseases (e.g., antiparasitic, antiviral, antibacterial, etc.) are effective, they present several undesirable pharmacological and pharmaceutical properties. Most of the drugs have low bioavailability, lack of sensitivity, and do not target only the damaged cells, thus also affecting normal cells. Moreover, there is the risk of developing resistance against drugs upon chronic treatment. Consequently, their potential clinical applications might be limited and therefore, it is mandatory to find strategies that improve those properties of therapeutic agents. The development of prodrugs using amino acids as moieties has resulted in improvements in several properties, namely increased bioavailability, decreased toxicity of the parent drug, accurate delivery to target tissues or organs, and prevention of fast metabolism. Herein, we provide an overview of models currently in use of prodrug design with amino acids. Furthermore, we review the challenges related to the permeability of poorly absorbed drugs and transport and deliver on target organs.
Collapse
Affiliation(s)
- Nuno Vale
- Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
- Institute of Molecular Pathology and Immunology of the University of Porto (IPATIMUP), Rua Júlio Amaral de Carvalho, 45, 4200-135 Porto, Portugal.
- Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal.
- Department of Molecular Pathology and Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
| | - Abigail Ferreira
- Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
- LAQV&REQUIMTE, Laboratory of Applied Chemistry, Department of Chemical Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
| | - Joana Matos
- SpiroChem AG, Rosental Area, WRO-1074-3, Mattenstrasse 24, 4058 Basel, Switzerland.
| | - Paula Fresco
- Laboratory of Pharmacology, Department of Drug Sciences, Faculty of Pharmacy, University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
| | - Maria João Gouveia
- Instituto de Investigação e Inovação em Saúde (i3S), University of Porto, Rua Alfredo Allen, 208, 4200-135 Porto, Portugal.
- Department of Molecular Pathology and Immunology, Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, Rua de Jorge Viterbo Ferreira 228, 4050-313 Porto, Portugal.
| |
Collapse
|
6
|
Levatić J, Pavić K, Perković I, Uzelac L, Ester K, Kralj M, Kaiser M, Rottmann M, Supek F, Zorc B. Machine learning prioritizes synthesis of primaquine ureidoamides with high antimalarial activity and attenuated cytotoxicity. Eur J Med Chem 2018; 146:651-667. [DOI: 10.1016/j.ejmech.2018.01.062] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/16/2017] [Revised: 01/16/2018] [Accepted: 01/18/2018] [Indexed: 01/24/2023]
|
7
|
Vale N, Correia-Branco A, Patrício B, Duarte D, Martel F. In vitro studies on the inhibition of colon cancer by amino acid derivatives of bromothiazole. Bioorg Med Chem Lett 2017; 27:3507-3510. [DOI: 10.1016/j.bmcl.2017.05.073] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2017] [Revised: 05/20/2017] [Accepted: 05/22/2017] [Indexed: 01/18/2023]
|
8
|
Aguiar ACC, Figueiredo FJB, Neuenfeldt PD, Katsuragawa TH, Drawanz BB, Cunico W, Sinnis P, Zavala F, Krettli AU. Primaquine-thiazolidinones block malaria transmission and development of the liver exoerythrocytic forms. Malar J 2017; 16:110. [PMID: 28279180 PMCID: PMC5345155 DOI: 10.1186/s12936-017-1755-6] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/12/2016] [Accepted: 02/26/2017] [Indexed: 02/06/2023] Open
Abstract
Background Primaquine is an anti-malarial used to prevent Plasmodium vivax relapses and malaria transmission. However, PQ metabolites cause haemolysis in patients deficient in the enzyme glucose-6-phosphate dehydrogenase (G6PD). Fifteen PQ-thiazolidinone derivatives, synthesized through one-post reactions from primaquine, arenealdehydes and mercaptoacetic acid, were evaluated in parallel in several biological assays, including ability to block malaria transmission to mosquitoes. Results All primaquine derivatives (PQ-TZs) exhibited lower cell toxicity than primaquine; none caused haemolysis to normal or G6PD-deficient human erythrocytes in vitro. Sera from mice pretreated with the test compounds thus assumed to have drug metabolites, caused no in vitro haemolysis of human erythrocytes, whereas sera from mice pretreated with primaquine did cause haemolysis. The ability of the PQ-TZs to block malaria transmission was evaluated based on the oocyst production and percentage of mosquitoes infected after a blood meal in drug pre-treated animals with experimental malaria caused by either Plasmodium gallinaceum or Plasmodium berghei; four and five PQ-TZs significantly inhibited sporogony in avian and in rodent malaria, respectively. Selected PQ-TZs were tested for their inhibitory activity on P. berghei liver stage development, in mice and in vitro, one compound (4m) caused a 3-day delay in the malaria pre-patent period. Conclusions The compound 4m was the most promising, blocking malaria transmissions and reducing the number of exoerythrocytic forms of P. berghei (EEFs) in hepatoma cells in vitro and in mice in vivo. The same compound also caused a 3-day delay in the malaria pre-patent period. Electronic supplementary material The online version of this article (doi:10.1186/s12936-017-1755-6) contains supplementary material, which is available to authorized users.
Collapse
Affiliation(s)
- Anna Caroline C Aguiar
- Centro de Pesquisas René Rachou-Fiocruz, Av. Augusto de Lima 1715, Belo Horizonte, MG, 30190-002, Brazil.,Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Alfredo Balena, 190, Belo Horizonte, MG, 30130-100, Brazil.,Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, MD, 21205, USA
| | - Flávio Jr B Figueiredo
- Centro de Pesquisas René Rachou-Fiocruz, Av. Augusto de Lima 1715, Belo Horizonte, MG, 30190-002, Brazil
| | - Patrícia D Neuenfeldt
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimentos, UFPel, Campus Universitário s/no, Pelotas, RS, 98001-970, Brazil
| | - Tony H Katsuragawa
- Laboratório de Epidemiologia, Fundação Osvaldo Cruz-Fiocruz Rondônia, Bairro Lagoa, Porto Velho, RO, Brazil
| | - Bruna B Drawanz
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimentos, UFPel, Campus Universitário s/no, Pelotas, RS, 98001-970, Brazil
| | - Wilson Cunico
- Laboratório de Química Aplicada à Bioativos, Centro de Ciências Químicas, Farmacêuticas e de Alimentos, UFPel, Campus Universitário s/no, Pelotas, RS, 98001-970, Brazil
| | - Photini Sinnis
- Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, MD, 21205, USA
| | - Fidel Zavala
- Department of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health, 615 N Wolfe St., Baltimore, MD, 21205, USA
| | - Antoniana U Krettli
- Centro de Pesquisas René Rachou-Fiocruz, Av. Augusto de Lima 1715, Belo Horizonte, MG, 30190-002, Brazil. .,Faculdade de Medicina, Universidade Federal de Minas Gerais, Av. Alfredo Balena, 190, Belo Horizonte, MG, 30130-100, Brazil.
| |
Collapse
|
9
|
A new procedure for N1-alkylation of imidazolidin-4-ones and its NMR characterization. J Mol Struct 2016. [DOI: 10.1016/j.molstruc.2016.07.005] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
|
10
|
Sonopo MS, Pillay A, Chibale K, Marjanovic-Painter B, Donini C, Zeevaart JR. Carbon-14 radiolabeling and tissue distribution evaluation of MMV390048. J Labelled Comp Radiopharm 2016; 59:680-688. [DOI: 10.1002/jlcr.3445] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2016] [Revised: 08/23/2016] [Accepted: 08/23/2016] [Indexed: 11/11/2022]
Affiliation(s)
| | | | - Kelly Chibale
- Drug Discovery and Development Centre (H3D) and South African Medical Research Council Drug Discovery and Development Research Unit, Department of Chemistry; University of Cape Town; Rondebosch South Africa
| | | | | | - Jan R. Zeevaart
- DST/NWU, Preclinical Drug Development Platform; North-West University; Potchefstroom South Africa
| |
Collapse
|
11
|
Ribeiro CJ, Espadinha M, Machado M, Gut J, Gonçalves LM, Rosenthal PJ, Prudêncio M, Moreira R, Santos MM. Novel squaramides with in vitro liver stage antiplasmodial activity. Bioorg Med Chem 2016; 24:1786-92. [DOI: 10.1016/j.bmc.2016.03.005] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/21/2016] [Accepted: 03/02/2016] [Indexed: 12/17/2022]
|
12
|
Sucu BO, Ocal N, Erden I. Direct synthesis of imidazolidin-4-ones via cycloadditions of imines with a Leuchs’ anyhdride. Tetrahedron Lett 2015. [DOI: 10.1016/j.tetlet.2015.04.002] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
13
|
Teixeira C, Vale N, Pérez B, Gomes A, Gomes JRB, Gomes P. "Recycling" classical drugs for malaria. Chem Rev 2014; 114:11164-220. [PMID: 25329927 DOI: 10.1021/cr500123g] [Citation(s) in RCA: 85] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/22/2022]
Affiliation(s)
- Cátia Teixeira
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto , P-4169-007 Porto, Portugal.,CICECO, Departamento de Química, Universidade de Aveiro , P-3810-193 Aveiro, Portugal
| | - Nuno Vale
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto , P-4169-007 Porto, Portugal
| | - Bianca Pérez
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto , P-4169-007 Porto, Portugal
| | - Ana Gomes
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto , P-4169-007 Porto, Portugal
| | - José R B Gomes
- CICECO, Departamento de Química, Universidade de Aveiro , P-3810-193 Aveiro, Portugal
| | - Paula Gomes
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química e Bioquímica, Faculdade de Ciências, Universidade do Porto , P-4169-007 Porto, Portugal
| |
Collapse
|
14
|
Miranda D, Capela R, Albuquerque IS, Meireles P, Paiva I, Nogueira F, Amewu R, Gut J, Rosenthal PJ, Oliveira R, Mota MM, Moreira R, Marti F, Prudêncio M, O’Neill PM, Lopes F. Novel endoperoxide-based transmission-blocking antimalarials with liver- and blood-schizontocidal activities. ACS Med Chem Lett 2014; 5:108-12. [PMID: 24900781 DOI: 10.1021/ml4002985] [Citation(s) in RCA: 39] [Impact Index Per Article: 3.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/30/2013] [Accepted: 12/20/2013] [Indexed: 11/29/2022] Open
Abstract
In a search for effective compounds against both the blood- and liver-stages of infection by malaria parasites with the ability to block the transmission of the disease to mosquito vectors, a series of hybrid compounds combining either a 1,2,4-trioxane or 1,2,4,5-tetraoxane and 8-aminoquinoline moieties were synthesized and screened for their antimalarial activity. These hybrid compounds showed high potency against both exoerythrocytic and erythrocytic forms of malaria parasites, comparable to representative trioxane-based counterparts. Furthermore, they efficiently blocked the development of the sporogonic cycle in the mosquito vector. The tetraoxane-based hybrid 5, containing an amide linker between the two moieties, effectively cleared a patent blood-stage P. berghei infection in mice after i.p. administration. Overall, these results indicate that peroxide-8-aminoquinoline hybrids are excellent starting points to develop an agent that conveys all the desired antimalarial multistage activities in a single chemical entity and, as such, with the potential to be used in malaria elimination campaigns.
Collapse
Affiliation(s)
- Daniela Miranda
- Research
Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty
of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| | - Rita Capela
- Research
Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty
of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| | - Inês S. Albuquerque
- Instituto
de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
| | - Patrícia Meireles
- Instituto
de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
| | - Isa Paiva
- Centro
de Malária e Outras Doenças Tropicais, IHMT, Universidade Nova de Lisboa, Rua da Junqueira No. 100, P-1349-008 Lisbon, Portugal
| | - Fátima Nogueira
- Centro
de Malária e Outras Doenças Tropicais, IHMT, Universidade Nova de Lisboa, Rua da Junqueira No. 100, P-1349-008 Lisbon, Portugal
| | - Richard Amewu
- Department
of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K
| | - Jiri Gut
- Department
of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94143, United States
| | - Philip J. Rosenthal
- Department
of Medicine, San Francisco General Hospital, University of California, San Francisco, San Francisco, California 94143, United States
| | - Rudi Oliveira
- Research
Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty
of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| | - Maria M. Mota
- Instituto
de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
| | - Rui Moreira
- Research
Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty
of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| | - Francesc Marti
- Department
of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K
| | - Miguel Prudêncio
- Instituto
de Medicina Molecular, Faculdade de Medicina da Universidade de Lisboa, Av. Prof. Egas Moniz, 1649-028 Lisboa, Portugal
| | - Paul M. O’Neill
- Department
of Chemistry, University of Liverpool, Liverpool L69 7ZD, U.K
| | - Francisca Lopes
- Research
Institute for Medicines and Pharmaceutical Sciences (iMed.UL), Faculty
of Pharmacy, University of Lisbon, Av. Prof. Gama Pinto, 1649-019 Lisbon, Portugal
| |
Collapse
|
15
|
Dechy-Cabaret O, Benoit-Vical F. Effects of Antimalarial Molecules on the Gametocyte Stage of Plasmodium falciparum: The Debate. J Med Chem 2012; 55:10328-44. [DOI: 10.1021/jm3005898] [Citation(s) in RCA: 36] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Affiliation(s)
- Odile Dechy-Cabaret
- CNRS, LCC (Laboratoire de Chimie de Coordination), 205 Route de Narbonne, BP
44099, F-31077 Toulouse Cedex 4, France
- Université de Toulouse, UPS, INPT, F-31077 Toulouse Cedex 4, France
| | - Françoise Benoit-Vical
- CNRS, LCC (Laboratoire de Chimie de Coordination), 205 Route de Narbonne, BP
44099, F-31077 Toulouse Cedex 4, France
- Université de Toulouse, UPS, INPT, F-31077 Toulouse Cedex 4, France
- Service de Parasitologie-Mycologie
and Faculté de Médecine de Rangueil, Centre Hospitalier Universitaire de Toulouse, Toulouse, France
| |
Collapse
|
16
|
Kaur K, Jain M, Khan SI, Jacob MR, Tekwani BL, Singh S, Singh PP, Jain R. Amino acid, dipeptide and pseudodipeptide conjugates of ring-substituted 8-aminoquinolines: Synthesis and evaluation of anti-infective, β-haematin inhibition and cytotoxic activities. Eur J Med Chem 2012; 52:230-41. [DOI: 10.1016/j.ejmech.2012.03.019] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/14/2012] [Revised: 03/09/2012] [Accepted: 03/11/2012] [Indexed: 10/28/2022]
|
17
|
Shiraki H, Kozar MP, Melendez V, Hudson TH, Ohrt C, Magill AJ, Lin AJ. Antimalarial activity of novel 5-aryl-8-aminoquinoline derivatives. J Med Chem 2010; 54:131-42. [PMID: 21141892 DOI: 10.1021/jm100911f] [Citation(s) in RCA: 50] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
In an attempt to separate the antimalarial activity of tafenoquine (3) from its hemolytic side effects in glucose-6-phosphate dehydrogenase (G6PD) deficiency patients, a series of 5-aryl-8-aminoquinoline derivatives was prepared and assessed for antimalarial activities. The new compounds were found metabolically stable in human and mouse microsomal preparations, with t(1/2) > 60 min, and were equal to or more potent than primaquine (2) and 3 against Plasmodium falciparum cell growth. The new agents were more active against the chloroquine (CQ) resistant clone than to the CQ-sensitive clone. Analogues with electron donating groups showed better activity than those with electron withdrawing substituents. Compounds 4bc, 4bd, and 4be showed comparable therapeutic index (TI) to that of 2 and 3, with TI ranging from 5 to 8 based on IC(50) data. The new compounds showed no significant causal prophylactic activity in mice infected with Plasmodium berghei sporozoites, but are substantially less toxic than 2 and 3 in mouse tests.
Collapse
Affiliation(s)
- Hiroaki Shiraki
- Division of Experimental Therapeutics, Walter Reed Army Institute of Research, Silver Spring, Maryland 20910, United States
| | | | | | | | | | | | | |
Collapse
|
18
|
Xu Z, Buechler T, Wheeler K, Wang H. A Three-Component Reaction Based on a Remote-Group-Directed Dynamic Kinetic Aza-Michael Addition: Stereoselective Synthesis of Imidazolidin-4-ones. Chemistry 2010; 16:2972-6. [DOI: 10.1002/chem.200903508] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
19
|
Matos J, Vale N, Collins MS, Gut J, Rosenthal PJ, Cushion MT, Moreira R, Gomes P. PRIMACENES: novel non-cytotoxic primaquine-ferrocene conjugates with anti-Pneumocystis carinii activity. MEDCHEMCOMM 2010. [DOI: 10.1039/c0md00082e] [Citation(s) in RCA: 24] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/21/2022]
|
20
|
Vale N, Prudêncio M, Marques CA, Collins MS, Gut J, Nogueira F, Matos J, Rosenthal PJ, Cushion MT, do Rosário VE, Mota MM, Moreira R, Gomes P. Imidazoquines as antimalarial and antipneumocystis agents. J Med Chem 2009; 52:7800-7. [PMID: 19799426 PMCID: PMC2788672 DOI: 10.1021/jm900738c] [Citation(s) in RCA: 29] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Peptidomimetic imidazolidin-4-one derivatives of primaquine (imidazoquines) recently displayed in vitro activity against blood schizonts of a chloroquine-resistant strain of Plasmodium falciparum. Preliminary studies with a subset of such imidazoquines showed them to both block transmission of P. berghei malaria from mouse to mosquito and be highly stable toward hydrolysis at physiological conditions. This prompted us to have deeper insight into the activity of imidazoquines against both Plasmodia and Pneumocystis carinii, on which primaquine is also active. Full assessment of the in vivo transmission-blocking activity of imidazoquines, in vitro tissue-schizontocidal activity on P. berghei-infected hepatocytes, and in vitro anti-P. carinii activity is now reported. All compounds were active in these biological assays, with generally lower activity than the parent drug. However, imidazoquines' stability against both oxidative deamination and proteolytic degradation suggest that they will probably have higher oral bioavailability and lower hematotoxicity than primaquine, which might translate into higher therapeutic indexes.
Collapse
Affiliation(s)
- Nuno Vale
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| | - Miguel Prudêncio
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Catarina A. Marques
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Margaret S. Collins
- Research Services, Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
- Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, OH 45267-0560, USA
| | - Jiri Gut
- Department of Medicine, San Francisco General Hospital, University of California, CA 94143-0811, USA
| | - Fátima Nogueira
- Centro de Malária e Outras Doenças Tropicais, IHMT - Universidade Nova de Lisboa, P-1349-008 Lisboa, Portugal
| | - Joana Matos
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| | - Philip J. Rosenthal
- Department of Medicine, San Francisco General Hospital, University of California, CA 94143-0811, USA
| | - Melanie T. Cushion
- Research Services, Veterans Affairs Medical Center, Cincinnati, OH 45220, USA
- Division of Infectious Diseases, Department of Internal Medicine, University of Cincinnati, OH 45267-0560, USA
| | - Virgílio E. do Rosário
- Centro de Malária e Outras Doenças Tropicais, IHMT - Universidade Nova de Lisboa, P-1349-008 Lisboa, Portugal
| | - Maria M. Mota
- Unidade de Malária, Instituto de Medicina Molecular, Faculdade de Medicina, Universidade de Lisboa, P-1649-028 Lisboa, Portugal
| | - Rui Moreira
- iMed.UL, CECF, Faculdade de Farmácia, Universidade de Lisboa, P-1600-083 Lisboa, Portugal
| | - Paula Gomes
- CIQUP – Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, P-4169-007 Porto, Portugal
| |
Collapse
|
21
|
Fernandes I, Vale N, de Freitas V, Moreira R, Mateus N, Gomes P. Anti-tumoral activity of imidazoquines, a new class of antimalarials derived from primaquine. Bioorg Med Chem Lett 2009; 19:6914-7. [DOI: 10.1016/j.bmcl.2009.10.081] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/03/2009] [Revised: 10/16/2009] [Accepted: 10/17/2009] [Indexed: 11/28/2022]
|
22
|
Chen X, Wei H, Chen Y, Li X. A Convenient Synthesis of Imidazolidin-4-onesviaDomino Reactions. Helv Chim Acta 2009. [DOI: 10.1002/hlca.200900010] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/06/2022]
|
23
|
Vale N, Matos J, Moreira R, Gomes P. Electrospray ionization mass spectrometry as a valuable tool in the characterization of novel primaquine peptidomimetic derivatives. EUROPEAN JOURNAL OF MASS SPECTROMETRY (CHICHESTER, ENGLAND) 2009; 15:627-640. [PMID: 19679943 DOI: 10.1255/ejms.1011] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/28/2023]
Abstract
Novel primaquine-derived antimalarials have been extensively characterized by electrospray ionization-ion trap mass spectrometry (ESI-MS). Experiments by in-source collision-induced dissociation (CID) in the nozzle- skimmer region (NSR) or by tandem-MS are shown to be most valuable tools for the physicochemical characterization of these 8-aminoquinolinic drugs that also bear the biologically relevant imidazolidin-4-one scaffold. It was possible to find parallelism between compound stability in the NSR and its reactivity towards hydrolysis at physiological pH and T. Moreover, tandem-MS fragmentation patterns were characteristic for each family, providing a means for structural distinction of isomers and allowing to find interesting correlations between the relative abundance of particular fragments and relevant structure-activity determinants, such as Charton steric parameter, v. In conclusion, this work provides solid grounds to establish ESI-MS as a key tool for the physicochemical characterization of biopharmaceuticals bearing the 8-aminoquinoline and/or the imidazolidin-4-one moieties.
Collapse
Affiliation(s)
- Nuno Vale
- Centro de Investigação em Química da Universidade do Porto, Departamento de Química, Faculdade de Ciências, Universidade do Porto, Porto, Portugal
| | | | | | | |
Collapse
|
24
|
Dude MA, Kaeppler U, Herb M, Schiller M, Schulz F, Vedder B, Heppner S, Pradel G, Gut J, Rosenthal PJ, Schirmeister T, Leippe M, Gelhaus C. Synthesis and evaluation of non-peptidic cysteine protease inhibitors of P. falciparum derived from etacrynic acid. Molecules 2008; 14:19-35. [PMID: 19104483 PMCID: PMC6253875 DOI: 10.3390/molecules14010019] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/20/2008] [Revised: 12/12/2008] [Accepted: 12/19/2008] [Indexed: 11/28/2022] Open
Abstract
A series of etacrynic acid derivatives was synthesized and screened for their in vitro activity against Plasmodium falciparum, as well as their activity against recombinantly expressed falcipain-2 and -3. The two most active compounds of the series displayed IC50 values of 9.0 and 18.8 μM against Plasmodia.
Collapse
Affiliation(s)
- Marie-Adrienne Dude
- Research Center for Infectious Diseases, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany; E-mail: (M-A. D.), (G. P.)
| | - Ulrich Kaeppler
- Institute of Pharmacy and Food Chemistry, Am Hubland, D-97074 Würzburg, Germany E-mail: (T. S.)
| | - Monika Herb
- Institute of Pharmacy and Food Chemistry, Am Hubland, D-97074 Würzburg, Germany E-mail: (T. S.)
| | - Markus Schiller
- Institute of Pharmacy and Food Chemistry, Am Hubland, D-97074 Würzburg, Germany E-mail: (T. S.)
| | - Franziska Schulz
- Zoological Institute, University of Kiel, Olshausenstr. 40, D-24098 Kiel, GermanyE-mail: (M. L.)
| | - Birgit Vedder
- Institute of Pharmacy and Food Chemistry, Am Hubland, D-97074 Würzburg, Germany E-mail: (T. S.)
| | - Saskia Heppner
- Zoological Institute, University of Kiel, Olshausenstr. 40, D-24098 Kiel, GermanyE-mail: (M. L.)
| | - Gabriele Pradel
- Research Center for Infectious Diseases, University of Würzburg, Röntgenring 11, 97070 Würzburg, Germany; E-mail: (M-A. D.), (G. P.)
| | - Jiri Gut
- Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94143-0811, USA; E-mail: (P-J. R.)
| | - Philip J. Rosenthal
- Department of Medicine, San Francisco General Hospital, University of California, San Francisco, CA 94143-0811, USA; E-mail: (P-J. R.)
| | - Tanja Schirmeister
- Institute of Pharmacy and Food Chemistry, Am Hubland, D-97074 Würzburg, Germany E-mail: (T. S.)
| | - Matthias Leippe
- Zoological Institute, University of Kiel, Olshausenstr. 40, D-24098 Kiel, GermanyE-mail: (M. L.)
| | - Christoph Gelhaus
- Zoological Institute, University of Kiel, Olshausenstr. 40, D-24098 Kiel, GermanyE-mail: (M. L.)
- Author to whom correspondence should be addressed; E-mail:
| |
Collapse
|
25
|
Vale N, Matos J, Moreira R, Gomes P. Amino acids as selective acylating agents: regioselective N1-acylation of imidazolidin-4-one derivatives of the antimalarial drug primaquine. Tetrahedron 2008. [DOI: 10.1016/j.tet.2008.09.058] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
26
|
Vale N, Matos J, Moreira R, Gomes P. Electrospray ionization-ion trap mass spectrometry study of PQAAPro and PQProAA mimetic derivatives of the antimalarial primaquine. JOURNAL OF THE AMERICAN SOCIETY FOR MASS SPECTROMETRY 2008; 19:1476-1490. [PMID: 18657994 DOI: 10.1016/j.jasms.2008.06.019] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/12/2008] [Revised: 06/20/2008] [Accepted: 06/20/2008] [Indexed: 05/26/2023]
Abstract
Electrospray ionization-ion trap mass spectrometry (ESI-MS) of imidazolidin-4-one peptidomimetic derivatives of the antimalarial drug primaquine (PQ) is reported. These compounds contain the imidazolidin-4-one moiety either at the N- or the C-terminal of a dipeptide backbone, thus respectively mimicking PQ-Amino Acid-Proline (PQAAPro) and PQProAA derivatives of PQ. Both the peptidomimetics and precursors previously developed by us are promising drug candidates, as they were found to be active against rodent Plasmodium berghei malaria and Pneumocystis carinii pneumonia. Collision-induced dissociation (CID) and tandem-mass spectra (MS) of the title compounds, and fragmentation pathways thereof, led to the following findings: (1) CID patterns present some parallelism with the reactivity towards hydrolysis previously found for the same or related compounds; (2) a positional shift of the imidazolidin-4-one ring is reflected on both degree and pathways of fragmentation, which makes tandem-MS a key tool for differentiation of imidazolidin-4-one isomers; (3) the major MS/MS fragmentation of PQProAA mimetics involves release of a neutral diketopiperazine (DKP), in parallel to the "diketopiperazine pathway" described in tandem-MS studies of oligopeptides; (4) the relative abundance of a major fragment in tandem-MS spectra is inversely correlated with the size of the N-terminal AA in PQProAA mimetics. Overall, this work embodies an original and valuable contribution towards a deeper insight into the molecular properties of novel antimalarials, which can be viewed as representative of both the 8-aminoquinoline and, especially, the imidazolidin-4-one structural classes.
Collapse
Affiliation(s)
- Nuno Vale
- CIQUP, Chemistry Department, Faculty of Sciences, University of Porto, Porto, Portugal
| | | | | | | |
Collapse
|